COLUMBUS CIRCLE INVESTORS - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2019$6,927,000
+46.8%
533,636
+37.8%
0.18%
+54.2%
Q1 2019$4,718,000
-11.1%
387,391
-16.8%
0.12%
-20.0%
Q4 2018$5,306,000
-50.5%
465,844
-5.6%
0.15%
-29.9%
Q3 2018$10,711,000
+15.3%
493,608
-6.1%
0.21%
+11.5%
Q2 2018$9,286,000
-20.7%
525,502
-5.5%
0.19%
-19.3%
Q1 2018$11,707,000
+150.3%
556,156
+72.2%
0.24%
+167.4%
Q4 2017$4,678,000
+88.5%
323,049
+105.4%
0.09%
+111.9%
Q3 2017$2,482,000
-59.9%
157,305
-58.7%
0.04%
-51.7%
Q1 2017$6,190,000
-21.0%
380,911
-26.6%
0.09%
-14.7%
Q4 2016$7,833,000
+31.6%
519,108
+32.9%
0.10%
+59.4%
Q3 2016$5,954,000
-72.2%
390,650
-29.2%
0.06%
-70.2%
Q2 2016$21,433,000
+95.4%
552,104
+39.9%
0.22%
+119.4%
Q1 2016$10,970,000
-43.9%
394,606
+8.6%
0.10%
-37.6%
Q4 2015$19,551,000
+99.4%
363,471
+48.5%
0.16%
+96.2%
Q3 2015$9,803,000244,8420.08%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q4 2017
NameSharesValueWeighting ↓
DCF Advisers, LLC 359,000$18,790,0007.62%
Velan Capital Investment Management LP 150,000$7,851,0006.09%
SILVERARC CAPITAL MANAGEMENT, LLC 195,000$10,206,0004.14%
Vantage Consulting Group Inc 226,670$11,864,0003.19%
Vahanian & Associates Financial Planning Inc. 71,742$3,755,0003.03%
Nicholas Investment Partners, LP 652,886$34,172,0002.16%
COOPER/HAIMS ADVISORS, LLC 61,116$3,199,0001.97%
Bellevue Group AG 3,628,919$189,938,0001.96%
WASATCH ADVISORS LP 8,235,171$431,029,0001.76%
Quantum Private Wealth, LLC 77,622$4,062,0001.54%
View complete list of INTRA CELLULAR THERAPIES INC shareholders